CrossAssetDataThe Company File
···
RPID

Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc. is classed by the SEC under Laboratory Analytical Instruments (industry code 3826), based in Lexington, MA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $34 million and a loss of $47 million (its filed statements).

Product business Laboratory Analytical Instruments Lexington, MA filings since 2006 8 of 9 filed, 1 estimated
Ask the desk about RPID → Compare RPID with BNGO → Price chart on TradingView ↗ Full EDGAR file ↗ Watch RPID →

Sector peers: BNGOHBIONAUTPRE

4.5/10headline grade
vs its business-model standard
4.0/10past 4.2/10present 5.6/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 3826, Laboratory Analytical Instruments); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 4.5 out of ten, 8 of 9 metrics filed and 1 estimated: past 4.0 out of ten, present 4.2 out of ten, future 5.6 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 3.5 out of ten. 3 warning events since 2017; the latest 2024-08-02. 35th percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 4.4 out of ten. +15.9% a year over 6 filed years; profitable in 0 of 6. 44th percentile among 21 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 4.0 out of ten. CrossAssetData estimate 4.0/10, confidence 35 of 100 (one part). 40th percentile among 21 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Financial health (present): 2.6 out of ten. ROE -142%: lost 142¢ per shareholder dollar. Leverage 56%: owes 56¢ per asset dollar. 26th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 5.0 out of ten. bottom 50% of 21 in its family; net margin -140.3%. 50th percentile among 21 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 6.2 out of ten. top 38% of 21 in its family for leadership; chief executive since 2021. 62nd percentile among 21 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 4.7 out of ten. bottom 47% of 21 in its family for room to expand. 47th percentile among 21 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 6.4 out of ten. top 36% of 21 in its family for growth drivers. 64th percentile among 21 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 6.1 out of ten. top 39% of 20 in its family for expectations against reality. 61st percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2026-03-12 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-07 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-07 (on EDGAR). Newest filing: Form SCHEDULE 13G/A, 2026-08-14. Filings on record since 2006. Read from EDGAR 2026-10-12.

Where the revenue comes from

Product and service lines in fiscal 2025: Product 70%, Service 30%. By geography: United States 40%, Switzerland 18%, All other countries 17%, Germany 17%, Japan 8%. As tagged in its annual report (Form 10-K, filed 2026-03-12).

Who runs it

Spignesi, Robert G. Jr. (PRESIDENT AND CEO); Wirtjes, Sean M (CHIEF FINANCIAL OFFICER); Wilson, John J. Addington (CHIEF OPERATING OFFICER); Kollender, Richard S (director); Lowenstein, Inese (director); Malloy, Kirk (director); Pei, Melinda Litherland (director); Bika, Dafni (director); Ricciardi, Natale S (director). 9 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.